| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.019 | 0.9 |